about
A single-question screen for rapid eye movement sleep behavior disorder: a multicenter validation study.Diffusion tensor imaging in idiopathic REM sleep behavior disorder reveals microstructural changes in the brainstem, substantia nigra, olfactory region, and other brain regions.Family history of idiopathic REM behavior disorder: a multicenter case-control study.Clinical risk-benefit assessment of dopamine agonists.Comorbidity and medication in REM sleep behavior disorder: a multicenter case-control study.Rapid eye movement sleep behavior disorder: devising controlled active treatment studies for symptomatic and neuroprotective therapy--a consensus statement from the International Rapid Eye Movement Sleep Behavior Disorder Study Group.Facial emotion recognition in Parkinson's disease: Association with age and olfaction.Acute Occlusions of Dual-Layer Carotid Stents After Endovascular Emergency Treatment of Tandem Lesions.High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types.Postprandial ghrelin response is reduced in patients with Parkinson's disease and idiopathic REM sleep behaviour disorder: a peripheral biomarker for early Parkinson's disease?Embryonic endothelial progenitor cells armed with a suicide gene target hypoxic lung metastases after intravenous delivery.Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study.Affective and cognitive Theory of Mind in patients with parkinson's disease.Real-life evaluations of compliance with mandatory drug safety monitoring exemplified with tolcapone in Parkinson's disease.Acylated and unacylated ghrelin confer neuroprotection to mesencephalic neurons.Does REM sleep behavior disorder have the guts to be Parkinson disease?Erratum to: Autonomic symptoms in idiopathic REM behavior disorder: a multicentre case-control study.Autonomic symptoms in idiopathic REM behavior disorder: a multicentre case-control study.Fecal markers of intestinal inflammation and intestinal permeability are elevated in Parkinson's disease.Diabetes and Parkinson disease: A sweet spot?Real-time visualization of altered gastric motility by magnetic resonance imaging in patients with Parkinson's diseaseShort chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controlsNonpharmacological Modulation of Chronic Inflammation in Parkinson's Disease: Role of Diet InterventionsImpact of oral COMT-inhibitors on gut microbiota and short chain fatty acids in Parkinson's diseaseLegionnaire's-disease-associated meningoencephalitis: A case reportEffect of Parkinson's disease and related medications on the composition of the fecal bacterial microbiotaThird ventricular width assessed by transcranial ultrasound correlates with cognitive performance in Parkinson's diseaseEarly poststroke seizures following thrombolysis and/or thrombectomy for acute stroke: Clinical and stroke characteristics
P50
Q24564550-A12C120C-459B-4835-B162-C2E09AC7FEA9Q33896828-184029F7-8363-4038-BF9D-77E0AA1E8E3DQ34651664-A38BA79E-26AA-4FEB-8126-AD11194F5EA9Q37243331-3DA7DA3A-7CAE-45E4-8F2C-156619DA7794Q37657040-31A67F4E-EC83-4EBD-A0FE-3AB2FE878939Q38124156-A03209FD-F763-4600-BD42-2791D88C294BQ38668372-A4AF7CF1-1A76-4BA0-B457-30494E7FB533Q38692262-BB64C430-FD89-48E5-AC18-F8427E3C4300Q42250827-8EACFC7C-B24E-4BEF-81E3-A73CE323E97CQ44014290-BE8CAAC8-59F1-4560-BDBC-6F9D1568308CQ44897194-CD8E562B-2905-464E-9415-C6995F6E7AC2Q44953314-F21EC301-AAF3-4F7C-8CCC-0AFC1E426FD0Q45049840-61B2755E-1711-4273-BD2F-9CF940B79953Q45909246-EF751865-E8F7-4AEA-AE07-4918811450ECQ47750940-C795E432-96AA-4375-B2A9-F6EDC18AA593Q47926679-1D65C494-EF45-4D26-8188-DE7672D3C9BDQ48008125-5721C1D8-6F67-46A9-A9EE-FD4FC2F55C15Q48116076-658F0DB7-9B6A-4CFC-AFCD-AEA999A33E06Q49897715-F3D8EE56-5C20-402D-BC54-B54A5D931E56Q64902698-E62CD3BF-5238-4519-8294-768FF916E829Q83158063-667AA4EB-F171-4F2B-9D79-BCAED7991AB1Q88257756-B0B21F12-D8CE-4860-B5C4-14288610C852Q90170424-913E8ABD-1202-4B91-912E-3B06150B91EAQ91608403-63F50EAB-8133-45A9-A4B0-8601F98D7018Q91722379-BFEDD46A-1FD9-4653-9E5E-36A340F1EE95Q91793896-E9DCB99D-394B-4D3D-B18F-EE8A79290418Q92032755-D1EF6042-DF70-4C18-A9B7-0681E8C490FCQ92969284-F032C0E7-0135-44A4-B3DB-2B3D53803F8E
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Marcus Michael Unger
@ast
Marcus Michael Unger
@en
Marcus Michael Unger
@es
Marcus Michael Unger
@nl
Marcus Michael Unger
@sl
type
label
Marcus Michael Unger
@ast
Marcus Michael Unger
@en
Marcus Michael Unger
@es
Marcus Michael Unger
@nl
Marcus Michael Unger
@sl
altLabel
M Unger
@en
Marcus M Unger
@en
Marcus M. Unger
@en
prefLabel
Marcus Michael Unger
@ast
Marcus Michael Unger
@en
Marcus Michael Unger
@es
Marcus Michael Unger
@nl
Marcus Michael Unger
@sl
P106
P21
P2798
P31
P4012
P496
0000-0003-0805-6968